Blueprint Investment Partners LLC Purchases 1,413 Shares of Colgate-Palmolive (NYSE:CL)

Blueprint Investment Partners LLC increased its position in shares of Colgate-Palmolive (NYSE:CL) by 57.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,871 shares of the company’s stock after acquiring an additional 1,413 shares during the quarter. Blueprint Investment Partners LLC’s holdings in Colgate-Palmolive were worth $352,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kohmann Bosshard Financial Services LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at approximately $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $27,000. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Briaud Financial Planning Inc acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $33,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.0 %

Shares of Colgate-Palmolive stock opened at $90.30 on Monday. The firm has a 50-day moving average of $89.33 and a 200-day moving average of $94.07. The stock has a market cap of $73.28 billion, a PE ratio of 25.65, a PEG ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the firm earned $0.87 earnings per share. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive announced that its board has authorized a stock buyback program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to buy up to 6.8% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a dividend of $0.52 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. This represents a $2.08 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on CL. Raymond James reiterated an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Finally, Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and an average price target of $101.72.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.